Live Longer. Live Healthier.Know Your Risks Earlier.

Precision Longevity is a physician-led approach to prevention and healthy ageing. It combines medical assessment, family history, lifestyle review, evidence-based laboratory testing and selected advanced diagnostics to identify modifiable health risks, and then builds an individualized prevention and monitoring plan. The focus is healthspan — health, function and independence as people age.

A routine check-up is usually a fixed package of tests given to everyone. Precision Longevity starts with clinical assessment and personal and family risk, then decides which investigations are actually appropriate. Results are followed over time as trends rather than read once in isolation, and the outcome is a plan rather than a report.

Adults who want a structured preventive assessment, people concerned about a family history of cancer or cardiovascular disease, people with metabolic risk factors, and people who have completed cancer treatment and need long-term health assessment. It is not an emergency or acute-care service.

There is no single fixed list. Baseline testing may cover blood counts, glucose and HbA1c, lipids, renal and liver function, selected thyroid assessment and urine testing. Further testing is directed by findings — for example ApoB or lipoprotein(a) for cardiovascular risk, vitamin D and bone assessment, or deficiency testing where clinically suspected. Testing is individualized according to age, sex, medical history, family history, medications and risk factors.

No. Genetic testing is recommended selectively when the personal or family history suggests that the result may meaningfully affect medical care, and it is offered with pre-test counselling and post-test interpretation. Whole-genome sequencing is not used as a routine longevity test.

Yes — through personal and family-history assessment, hereditary risk evaluation where indicated, lifestyle and metabolic risk assessment, and a review of whether age- and risk-appropriate screening is up to date. No assessment can detect every cancer or rule cancer out, and screening reduces rather than removes the risk of a late diagnosis.

Cancer survivorship connects cancer treatment with long-term health. The program supports appropriate monitoring of treatment-related risks while helping survivors address cardiovascular, metabolic, bone, nutritional and functional health. It works alongside the follow-up arranged by the treating oncology team and does not replace it.

It depends on the findings. Someone with well-controlled risk factors may be reviewed annually, while an abnormal result, a new symptom or a treatment change may warrant earlier reassessment. The timing is agreed as part of the plan rather than fixed in advance.

Where available, AI-assisted tools may help organize longitudinal health information, identify trends and present complex results in an easier-to-understand format. AI-generated information is supportive only. It does not diagnose, prescribe or change treatment — clinical decisions are made by qualified healthcare professionals.

No medical program can guarantee reversal of ageing. The Precision Longevity Program focuses on identifying modifiable health risks, supporting evidence-based prevention and maintaining health and function as people age.